• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number CVD0095
Device Problem Biocompatibility (2886)
Patient Problems Endocarditis (1834); Tachycardia (2095); Alteration In Body Temperature (2682)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, a patient had the amplatzer duct occluder explanted after approximately two weeks due to endocarditis.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported in an article titled, "infective endocarditis developing early after percutaneous closure of a patent ductus arteriosus in a child using the amplatzer duct occluder ii" that a patient underwent patent ductus arteriosus closure using the amplatzer duct occluder ii device and was discharged a day after the procedure.After 1 week, she presented with tachypnoea, fatigue, and a fever.Blood cultures were performed, the patient became hospitalized and was placed on empirical antibiotherapy.The initial echocardiogram (ecg) revealed the device was in an appropriate position.Consecutive blood cultures yielded staphylococcus aureus in all seven blood cultures started during the first 3 days.The device was explanted, the fever abated and the patient's general condition improved immediately after the operation.The final ecg revealed no residual shunt and she was reported to be discharged 4 weeks after the cardiac procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER II
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key9986428
MDR Text Key188561676
Report Number2135147-2020-00174
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCVD0095
Device Catalogue NumberCVD0095
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Other; Required Intervention;
Patient Age10 MO
-
-